Elsevier

Vaccine

Volume 35, Issue 13, 23 March 2017, Pages 1692-1697
Vaccine

Risk stacking of pneumococcal vaccination indications increases mortality in unvaccinated adults with Streptococcus pneumoniae infections

https://doi.org/10.1016/j.vaccine.2017.02.026Get rights and content

Abstract

Background

Several chronic disease states have been identified as pneumococcal vaccination indications due to their ability to increase pneumococcal disease development and subsequent mortality. However, the risk of mortality according to the number of these disease states present is unknown. We sought to determine the impact of concomitant, multiple risk factors (stacked risks) for pneumococcal disease on 30-day mortality in adults.

Methods

This was a national case-control study of unvaccinated older Veterans (≥50 years of age) admitted to Veterans Affairs medical centers from 2002 to 2011 with serious pneumococcal infections (pneumonia, bacteremia, meningitis) based on positive S. pneumoniae blood, cerebrospinal fluid, or respiratory cultures, respectively. Cases were those not alive 30 days following culture, while controls were alive. Using logistic regression, we quantified risk of 30-day mortality among patients with stacked risk factors, including age ≥65 years, alcohol abuse, chronic heart disease, chronic liver disease, chronic respiratory disease, diabetes mellitus, immunodeficiency, and smoking.

Results

We identified 9730 serious pneumococcal infections, with an overall 30-day mortality rate of 18.6% (1764 cases, 7966 controls). Infection types included pneumonia (62%), bacteremia (26%), and bacteremic pneumonia (11%). Along with eight individual risk factors, we assessed 247 combinations of risk factors. Most cases (85%) and controls (74%) had at least two risk factors. Mortality increased as risks were stacked, up to six risk factors (one: OR 1.5, CI 1.08–2.07; two: OR 2.01, CI 1.47–2.75; three: OR 2.71, CI 1.99–3.69; four: OR 3.27, CI 2.39–4.47; five: OR 3.63, CI 2.60–5.07; six: OR 4.23, CI 2.69–6.65), with each additional risk factor increasing mortality an average of 55% (±13%).

Conclusions

Among adults ≥50 years with serious pneumococcal disease, mortality risk increased approximately 55% as vaccination indications present increased. Mortality with six stacked indications was double that of two indications.

Introduction

Serious Streptococcus pneumoniae infections, including pneumonia, bacteremia, and meningitis, are a major cause of morbidity and mortality among older adults [1], [2], [3]. Since the 1980s, vaccines to prevent pneumococcal disease have been used on a global scale to mitigate the risks associated with these bacterial infections [4]. The Advisory Committee on Immunization Practices (ACIP) recommends administration of the pneumococcal vaccination to adults with certain risk factors for pneumococcal disease, including age  65 years, alcoholism, heart disease and heart failure, chronic respiratory disease, hepatic dysfunction, immunodeficiency, and smoking, in an effort to prevent invasive pneumococcal disease (IPD) and subsequent poor outcomes [3].

Recent research has revealed that the presence of multiple, concomitant risk factors (risk stacking), particularly those conditions identified by ACIP as indications for pneumococcal vaccination, increases the likelihood of developing pneumococcal disease beyond the risk posed by individual risk factors alone [5], [6]. As our population ages, it is becoming more common for patients to have two or more risk factors [6]. However, the impact of risk stacking on outcomes, namely mortality, of adults who end up developing pneumococcal disease remains unknown. Furthermore, current data on risk stacking are limited in that there is no information regarding the impact of risk stacking “at-risk” conditions (e.g., alcoholism, heart disease, liver disease, cigarette smoking) with “high-risk” conditions (e.g., immunodeficiency) [5], [6], [7]. As such, the purpose of this study was to quantify the impact of stacking risk factors for developing pneumococcal disease on 30-day mortality among unvaccinated older adults.

Section snippets

Methods

Using national Veterans Health Administration databases, we conducted a nested case-control study of older Veterans (age  50 years) with positive S. pneumoniae blood, cerebrospinal fluid, or respiratory cultures between January 1, 2002 and December 31, 2011. We defined serious pneumococcal infections as culture-positive pneumonia, bacteremia, and meningitis. Cases were those individuals who died from any cause within 30 days of positive culture, and controls were those alive at 30 days. Patients

Results

We identified 9730 serious pneumococcal infections in 9468 unvaccinated individuals, with a 30-day mortality rate of 18.6% (1764 cases and 7966 controls; Table 1). The primary infection types, determined from positive cultures, included pneumonia (cases n = 871, 49.4%; controls n = 5204, 65.3%), bacteremia (cases n = 585, 33.2%; controls n = 1969, 24.7%), and bacteremic pneumonia (cases n = 305, 17.3%; controls n = 755, 9.5%). Meningitis accounted for <1% of infections among cases and among controls.

There

Discussion

We quantified the impact of stacking pneumococcal disease risk factors on 30-day mortality in unvaccinated older Veterans with serious pneumococcal infections. Of the 8 individual risk factors assessed, 37.5% of them significantly increased the risk of death and of the 247 stacked risks, 35% significantly increased the risk of death. Current literature regarding predictors of mortality in the setting of pneumococcal disease is primarily related to the impact of individual predictors,

Conclusion

In unvaccinated older Veterans with serious pneumococcal disease, the presence of multiple ACIP risk factors for developing pneumococcal disease was associated with higher 30-day all-cause mortality. The more indications for vaccination present, the greater the risk of death, which was almost three times higher among those with six stacked risk factors as opposed to a single risk factor. As multiple risk factors for pneumococcal disease are common among older adults, effective vaccination

Funding

This study was supported, in part, by an Advancing Science through Pfizer Initiated Research (ASPIRE) grant from Pfizer Inc.

Conflict of interest

Jacob Morton has no reported financial relationships relevant to this article. Haley Morrill has received research funding from Merck. Kerry LaPlante has received research funding and/or served as a scientific advisor or consultant for Merck (Cubist), BARD/Davol, Allergan (Forest Laboratories and Durata Therapeutics), The Medicines Company, and Pfizer Inc. Aisling Caffrey has received research funding from Pfizer Inc, Merck (Cubist), and The Medicines Company.

Acknowledgement

The views expressed are those of the authors and do not necessarily reflect the position or policy of the United States Department of Veterans Affairs. This material is based upon work supported, in part, by the Office of Research and Development, Department of Veterans Affairs. JBM was supported by Office of Academic Affiliations, Department of Veterans Affairs, and HJM is supported in part by a VA New England Career Development Award.

References (26)

  • D. van de Beek et al.

    Clinical features and prognostic factors in adults with bacterial meningitis

    N Engl J Med

    (2004)
  • M. Kalin et al.

    Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries

    J Infect Dis

    (2000)
  • S. Hanada et al.

    Host factors and biomarkers associated with poor outcomes in adults with invasive pneumococcal disease

    PLoS ONE

    (2016)
  • Cited by (19)

    View all citing articles on Scopus
    View full text